RenovaCare Inc RCAR
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.07 / $0.10
- Shares Outstanding
- 87.35M
- Market Cap
- $87.35
- Volume/Avg
- 160 / 697
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
RenovaCare Inc is a biotechnology company focusing on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The company's initial products under development target skin. It offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). RenovaCare is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma. Geographically all the activities are functioned through the region of United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1
- Website
- https://www.renovacareinc.com
Valuation
|
Metric
|
RCAR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RCAR
|
|---|---|
Quick Ratio | 0.06 |
Current Ratio | 0.62 |
Interest Coverage | −4,984.74 |
Quick Ratio
RCAR
Profitability
|
Metric
|
RCAR
|
|---|---|
Return on Assets (Normalized) | −172.62% |
Return on Equity (Normalized) | −585.80% |
Return on Invested Capital (Normalized) | −358.50% |
Return on Assets
RCAR
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|n$prbn | LOCK|!Qxr | $138B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|dK>d>lw | LOCK|LQrr | $85B | |||
| argenx SE ADR
ARGX
| LOCK|>MC@qb | LOCK|Q> | $65B | |||
| Moderna Inc
MRNA
| LOCK|>x@N<hz | LOCK|RGY | $58B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|M$^ty@ | LOCK|BH | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|R$lKstC | LOCK|Sn$p? | $36B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|t%^?&HB | LOCK|d<@Q< | $28B | |||
| BioNTech SE ADR
BNTX
| LOCK|w<>w#C | LOCK|<L^ | $26B | |||
| Incyte Corp
INCY
| LOCK|?KzmTD< | LOCK|Ng | $26B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|@?ysVt | LOCK|gdH | $16B |
United States